Mon Dec 20, 2021 – 6:14 am EST
LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here.
(Children’s Health Defense) – An advisory panel to the Centers for Disease Control and Prevention (CDC) voted 15 – 0 on Thursday to “preferentially recommend” mRNA COVID vaccines Pfizer and Moderna over the Johnson & Johnson (J&J) shot for adults 18 years and older.
The recommendation came after the agency’s advisory panel said the rate of rare blood-clotting disorders following the J&J vaccine was higher than expected. The CDC signed off on the panel’s updated guidance late Thursday.
The Advisory Committee on Immunization and Practices (ACIP) effectively discouraged vaccine providers and adults from using the J&J’s shot — marking the first time the panel expressed a preference for a specific type of COVID vaccine.
The panel stopped short of recommending the vaccine be pulled from the market. J&J’s vaccine will remain an option for people who are “unable or unwilling” to receive mRNA vaccines, The New York Times reported.
The ACIP said the interim recommendation applies to J&J’s primary series vaccine doses and its booster dose.
Panel members requested stronger language be used in the guidance, but CDC officials said the strength of the recommendations would be made
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors